Michael Secora is listed as an executive officer on 3 SEC Form D filings by 1 issuer between Nov 2025 and Sep 2026: Iambic Therapeutics, Inc. (San Diego, CA — biotechnology — 2025–2026; $103.2M reported sold to 22 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Evan Rachlin (3 shared filings), Fred Manby (3 shared filings), Jishnu Bhattacharjee (3 shared filings), Kurt von Emster (3 shared filings), Mary Tagliaferri (3 shared filings) and 7 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Michael. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 1 court case matching the name, 2 bankruptcy cases matching the name listed in Key records below.
What this means 3 records came back, including 1 court case still open — open cases can take years and cost money. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 3 public filings for Michael Secora and found 4 differences, 2 worth asking the sponsor about: Bankruptcy case: John C. Lambert and Secora T Lambert; Bankruptcy case: John Lambert and Secora Lambert; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.